Efficacy of aprotinin in children undergoing craniofacial surgery

Journal of Neurosurgery

Volumn 99, Issue 2, 2003, Pages 287-290

  D'Errico, Celia C ^a   Munro, Hamish M ^b   Buchman, Steven R ^b   Wagner, Deborah ^b   Muraszko, Karin M ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NONE

Author keywords

Anesthesia; Blood transfusion; Children; Pediatric neurosurgery; Plastic surgery

Indexed keywords

APROTININ;

ARTICLE; BLOOD TRANSFUSION; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIOFACIAL SURGERY; DEMOGRAPHY; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEMATOCRIT; HUMAN; MALE; PEDIATRIC SURGERY; PLASTIC SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

EID: 0041343282     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2003.99.2.0287     Document Type: Article

References (18)

1. Boldt J, Knothe C, Zickmann B, et al: Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss. J Thorac Cardiovasc Surg 105:705-711, 1993
2. Curran JW, Lawrence DN, Jaffe H, et al: Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med 310:69-75, 1984
3. Davies MJ, Allen A, Kort H, et al: Prospective, randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations. Ann Thorac Surg 63:497-503, 1997
4. D'Errico CC, Shayevitz JR, Martindale SJ, et al: The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery. Anesth Analg 83:1193-1199, 1996
5. Dietrich W, Mossinger H, Spannagl M, et al: Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Thorac Cardiovasc Surg 105:712-720, 1993
6. Dietrich W, Spath P, Ebell A, et al: Prevalence of anaphylactic reactions to aprotinin: Analysis of two hundred forty-eight reexposures to aprotinin in heart operations. J Thorac Cardiovasc Surg 113:194-201, 1997
7. Garcia-Huete L, Domenech P, Sabate A, et al: The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study. Hepatology 26:1143-1148, 1997
8. Lackritz EM, Satten GA, Aberle-Grasse J, et al: Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 333:1721-1725, 1995
9. Levy JH, Pifarre R, Schaff HV, et al: A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. Circulation 92:2236-2244, 1995
10. Marcel RJ, Stegall WC, Suit CT, et al: Continuous small-dose aprotinin controls fibrinolysis during orthotopic liver transplantation. Anesth Analg 82:1122-1125, 1996
11. McCullough J: The nation's changing blood supply system. JAMA 269:2239-2245, 1993
12. Miller RD: Transfusion therapy, in Miller RD, Cucchiara RF, Miller ED Jr, et al (eds): Anesthesia, ed 4. New York: Churchill Livingstone, 1994, Vol 2, pp 1619-1646
13. Nagaoka H, Yamada T, Hatano R, et al: Clinical significance of bradykinin liberation during cardiopulmonary bypass and its prevention by a kallikrein inhibitor. Jpn J Surg 5:222-233, 1975
14. Primack C, Walenga JM, Koza MJ, et al: Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operations. Ann Thorac Surg 61:1188-1193, 1996
15. Ranucci M, Corno A, Pavesi M, et al: Renal effects of low dose aprotinin in pediatric cardiac surgery. Minerva Anestesiol 60:361-366, 1994
16. Royston D, Bidstrup BP, Taylor KM, et al: Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 2:1289-1291, 1987
17. van Oeveren W, Jansen NJ, Bidstrup BP, et al: Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg 44:640-645, 1987
18. Wachtfogel YT, Hack CE, Nuijens JH, et al: Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation. Am J Physiol 268:H1352-H1357, 1995